Newron Pharmaceuticals S.p.A.Newron Pharmaceuticals S.p.A.Newron Pharmaceuticals S.p.A.

Newron Pharmaceuticals S.p.A.

No trades
See on Supercharts

Price target

14.450.000.00%
The 3 analysts offering 1 year price forecasts for NWRN have a max estimate of — and a min estimate of —.

Analyst rating

Based on 2 analysts giving stock ratings to NWRN in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


NWRN EPS for the last quarter is  CHF despite the estimation of −0.38 CHF. In the next quarter EPS is expected to reach −1.29 CHF. Track more of Newron Pharmaceuticals S.p.A. financials and stay on top of what is up with the company.
In the next quarter Newron Pharmaceuticals S.p.A. revenue is expected to reach ‪3.36 M‬ CHF. Check out Newron Pharmaceuticals S.p.A. revenue and earnings and make informed decisions.
According to analysts, NWRN price target is 14.45 CHF with a max estimate of 20.37 CHF and a min estimate of 11.49 CHF. Check if this forecast comes true in a year, meanwhile watch Newron Pharmaceuticals S.p.A. stock price chart and keep track of the current situation with NWRN news and stock market news.